Pancreatic Cancer Treatment at CMN Hospital
Many pancreatic cancer patients who come to CMN Hospital have already undergone surgery, chemotherapy, radiation, immunotherapy, targeted therapies, or combinations of multiple treatments before arriving. Others are newly diagnosed and searching for a more organized inpatient approach to care before their body becomes too weak to travel safely.
Pancreatic cancer can place a heavy physical burden on the body, often affecting digestion, appetite, weight, energy, strength, and comfort. By the time many patients arrive, they may feel depleted from the disease itself, prior treatments, pain, weight loss, and the emotional stress of trying to decide what to do next.
At CMN Hospital, Dr. Edgar Payán reviews each patient’s diagnosis, imaging, pathology, lab work, prior treatments, current symptoms, and overall condition before creating an individualized inpatient plan. Therapies are selected and adjusted throughout care based on the patient’s response during the program.
Why Pancreatic Cancer Often Resists Chemotherapy
Pancreatic ductal adenocarcinoma is biologically different from many other cancers. Its dense fibrotic tissue, known as desmoplastic stroma, can limit blood flow and make it harder for chemotherapy drugs to fully penetrate the tumor.
Pancreatic tumors are also often oxygen-poor. This low-oxygen environment can activate survival pathways within cancer cells and make treatment response more difficult. Common genetic changes, including KRAS, TP53, CDKN2A, and SMAD4, may also contribute to treatment resistance and disease progression.
When pancreatic cancer spreads to the liver, treatment can become even more complex. The liver’s biology, blood flow, detoxification role, and immune environment may create additional challenges, especially when the patient is already experiencing weight loss, fatigue, pain, digestive difficulty, or reduced physical strength.
Helping the Body Regain Strength During Care
Chemotherapy drugs are designed to target rapidly dividing cells, which is one reason patients may experience lowered blood counts, fatigue, digestive difficulty, appetite changes, weakness, and increased physical exhaustion during or after treatment.
Inside CMN Hospital’s inpatient program, care focuses on individualized treatment planning while also helping patients regain hydration, nutritional stability, immune function, oxygenation, and physical strength during their stay.
Depending on the patient’s diagnosis, condition, and treatment history, care may include IV nutrient therapy, dendritic cell therapy, autologous bone marrow stem cell therapy, Hyperbaric Oxygen Therapy, Ultraviolet Blood Irradiation, Major Autohemotherapy ozone therapy, nutrition, laboratory monitoring, and additional therapies selected by Dr. Payán during the inpatient program.
Scientific References
Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma — NIH